Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Typhus Fever Treatment Market size was valued at USD 60.56 billion in 2024 and is set to exceed USD 211.55 billion by 2037, registering over 10.1% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of typhus fever treatment is evaluated at USD 65.76 billion.
The growth of the market can be attributed to the increasing incidences of typhus fever across the globe Moreover, there has been a surging mortality rate if proper treatment is not taken at the right time. According to the data in 2019, scrub typhus may have a mortality rate of nearly 30 % if it is not treated early.
The lack of sanitation is another major factor responsible for the outbreaks of typhus fever, especially in underdeveloped countries. According to the data from the World Health Organization (WHO), 2 billion people globally do not have access to basic sanitation facilities, such as toilets, and 673 million people still defecate in the open. Furthermore, a lack of clean water and sanitation is set to drive the growth of this market in the future. Clean water and sanitation are essential for preventing typhus fever, However, many people in low and middle-income countries do not have access to these basic needs as a result they end up getting affected by this disease.
Typhus Fever Treatment Sector: Growth Drivers and Challenges
Growth Drivers
- Increasing Number of People Living in Crowded Areas - Housing overcrowding or people living in overcrowded conditions, is major factor estimated to boost the typhus fever treatment market growth. As per the data by Organization for Economic Co-operation and Development (OECD), a household is considered as overcrowded if less than one room is available in each household for every couple, individual above 18 years, and a pair of children below 18 years. Mexico is one of the most overcrowded countries in the world, with 33.191% of the population living in overcrowded households.
- Growing Research and Development - It is possible that a number of new opportunities will be created in order to boost this typhus fever treatment market growth during the forecast period, due to an increase in R&D initiatives and favorable government support. Due to advances in treatment, pharmaceutical companies are making investments in research and development efforts on novel drugs and therapeutic approaches.
- Presence of Well-Developed Healthcare Infrastructure - Owing to increasing urbanization and development in the healthcare domain the healthcare infrastructure all across the globe is advancing leading to the rise in the typhus fever treatment market in the projected period.
Challenges
- Increasing Emergence of Antibiotic-Resistant Strains - The medical community is increasingly worried about the emergence of antimicrobial-resistant strains of Salmonella typhi. The need to develop new and innovative treatment options for the fight against drug-resistant strains is therefore created. This is predicted to pose a restriction on the market expansion of typhus fever treatment in the upcoming time period.
- Lack of Accessibility to Treatment is Predicted to Hamper the Market Growth in the Upcoming Period.
- Unavailability of Vaccines on Large Scale for this Treatment are Set to Restrict the Market Growth in the Upcoming Future.
Typhus Fever Treatment Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
10.1% |
|
Base Year Market Size (2024) |
USD 60.56 billion |
|
Forecast Year Market Size (2037) |
USD 211.55 billion |
|
Regional Scope |
|
Typhus Fever Treatment Segmentation
Type (Murine Typhus, Epidemic, Scrub Typhus)
In terms of type, the scrub typhus segment in the typhus fever treatment market is set to hold the highest revenue share of 40% during the time period between 2025 - 2037. The significant rise in the cases of scrub typhus fever is expected to drive the market growth in the forecast period. Similarly, the growth in the market for scrub typhus treatment is also expected to be stimulated by rising cases of infections caused by bacteria as well as improved healthcare infrastructure. More than a million new cases are diagnosed each year, and it is estimated that more than 1 billion people worldwide are at risk of typhus.
Treatment (Antibiotics, Pain Medication)
Typhus fever treatment market from the antibiotics segment is set to hold the largest share by the end of 2036. This increase is due to increased efforts by governments and regulators to control and treat infectious diseases, further promoting the use of antibiotics in various healthcare settings. Furthermore, continued research and development efforts by pharmaceutical companies aimed at discovering new antibiotics and improving existing antibiotics will lead to the introduction of more effective and targeted treatments, thereby increasing the number of antibiotics on the market. Therefore, the segment's dominance is expected to strengthen. Additionally, global efforts to fight infectious diseases are expected to propel the growth of the antibiotics sector in the studied period.
Our in-depth analysis of the global typhus fever treatment market includes the following segments:
|
Type |
|
|
Treatment |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportTyphus Fever Treatment Industry - Regional Synopsis
North American Market Forecasts
North America industry is estimated to dominate majority revenue share of 35% by 2037, due to rising cases of typhus fever and prevalence of market players in the region.. The growth of this market can be attributed on the back of increasing prevalence of typhus fever in the region backed by increasing cases of mite and bug infestation. Moreover, the market position is strengthened through the presence of prominent participants and their products. In order to ensure the availability for typhus of innovative and efficient treatments, these companies take an active part in research and development activities. Moreover, market growth is expected to be stimulated by investments and collaboration between key players as a result of restrictions on the use of antibiotics in treating typhus fever.
APAC Market Statistics
The Asia Pacific typhus fever treatment market is set to grow substantially by the end of 2036. The growth can be attributed to poor housing conditions, overpopulation, and lack of healthcare awareness. According to the statistics by the World Health Organization (WHO), around 827,000 people in low- and middle-income countries die due to inadequate sanitation. Rapidly improving medical infrastructure, increasing disposable income, the availability of highly advanced healthcare facilities, increased health spending, and government measures aimed at reducing mortality due to typhus are also factors contributing to regional growth. Furthermore, the growth prospects for the Asia Pacific typhus treatment market are expected to be much higher during the forecast period with increasing healthcare tourism in India and China.
Companies Dominating the Typhus Fever Treatment Landscape
- Biogen, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Glenmark Pharmaceuticals
- Merck KGaA
- Novartis AG
- Sanofi-aventis Groupe
- Teva Pharmaceutical Industries Ltd.
- Boehringer Ingelheim International GmbH
- Siemens Healthcare GmbH
In the News
- ViiV Healthcare, collectively owned b GlaxoSmithKline plc, Pfizer Inc. and Shionogi announced approval of the U.S. Food and Drug Administration (FDA) for cabotegravir as an antiviral drug.
- GlaxoSmithKline pic and Vir Biotechnology, Inc. to conduct the Phase 3 trial of sotrovimab antimicrobial drug.
Author Credits: Radhika Pawar
- Report ID: 3653
- Published Date: Jan 03, 2025
- Report Format: PDF, PPT
